Search
Search results
172 results found
Intern Students
New Publication - Congratulations Dr Marti Ortega-Ribera (Postdoctoral fellow) on publication in the JHEP Report, October 2025
Ortega-Ribera M, Joshi R, Guixé-Muntet S, Brezani V, Nagesh PT, Brezani V, Patel A, Zhuang Y, Babuta M, Gracia-Sancho J, Szabo G. Transcriptome of monocytes from liver, brain and bone marrow reveals organ-specific features in aging and alcohol misuse. JHEP Rep. 2025 Oct 9;7(12):101603. doi: 10.1016...
Press Coverage : The New York Times, Feb. 6, 2025 - Gyongyi Szabo, MD, PhD (Chief Academic Officer, BILH) and other experts discussed the many ways alcohol can negatively affect your gastrointestinal tract.
Check out the article link here : https://www.nytimes.com/2025/02/06/well/eat/alcohol-bloating-acid-reflu…
yyyy
Dr Gyongyi Szabo receives 2025 AASLD Distinguished Achievement Award
Congratulations to Dr Gyongyi Szabo for the prestigious Distinguished Achievement Award in 2025 from the American Association for the Study of Liver Disease (AASLD)! This honor recognizes Dr. Szabo’s pioneering contributions to the liver field, from uncovering the role of the NLRP3 inflammasome and...
Lab Members
Innate Immune Signaling Pathways
The pathomechanism of alcoholic liver disease (ALD) involves cumulative events such as leaky gut, hepatocyte damage and inflammation that collectively contribute to the severity of disease. Our studies have delineated the role of Toll-like receptor 4 (TLR4) signaling and identified a unique role for...
microRNAs and Extracellular Vesicles
microRNAs in Alcoholic Liver Disease Alcoholic liver disease affects millions of people worldwide and it remains to be a therapeutic challenge for clinicians. Activation of the inflammatory cascade via gut-derived lipopolysaccharide (LPS) contributes to alcoholic liver disease via induction of pro...